Caffeine Completed Phase 1 Trials for Pharmacokinetics of Dextromethorphan / Pharmacokinetics of Caffeine / Prostate Cancer Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT02225093A Study to Evaluate How Daily Dosing With Enzalutamide Affects the Metabolism of Caffeine and Dextromethorphan in Men With Prostate Cancer